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Reply to Whittemore and Shih
To the Editor:
We thank Whittemore and Shih for their thoughtful dis-
cussion of our paper and are indebted to them for de-
tecting two errors in the estimate of the P value in gender
skewing and the calculation of the component b. The
former led us to underemphasize the significance of the
gender skewing, whereas the latter approximation ap-
pears to have had little effect.
We agree that both the LOD-score method and the b
analysis have failings, as discussed in our paper. Whit-
temore and Shih appropriately point out additional lim-
itations. Parametric linkage analysis conceivably allows
for v to be determined as a function of gender skewing.
For Leri-Weill dyschondrosteosis (LWD), where there is
little evidence of genetic heterogeneity, the calculated re-
lationship is likely to remain correct. The range of v,
however, is subject not only to errors from lack of ap-
preciation of complexity, as Whittemore and Shih re-
mind us, but also to genetic-model misspecification and,
therefore, remains highly uncertain. It is worth noting
that the largest sibships concordant for Hodgkin disease
(HD) (i.e., those with four or five affected children, as
shown in table 3 of our article) demonstrate the greatest
sex concordance, supporting the assertion that, if there
were to be an HD gene situated in the pseudoautosomal
region (PAR), then it is rather more likely to be cen-
tromerically situated than what is suggested from the
calculated v of the complete data set (i.e., including table
2 of our article). The b analysis suffers from the inability
to measure the genetic distance between the putative
locus and the marker—here, phenotypic sex. Neither
approach is ideal when the marker is nothing but the
sex of the patient as reported in the literature.
We wish to continue to emphasize the speculative na-
ture of the hypothesis that an HD gene resides in the
PAR. This conjecture can only be validated by studies
utilizing a distribution of molecular genetic markers
within the PAR. Because the PAR can easily be over-
looked in genomewide screens for linkage and because
two lines of evidence, gender concordance and the
unique family segregating both HD and LWD, lead to
the suggestion of a PAR locus, we ask that this hypoth-
esis not be overlooked should sufficient clinical samples
ultimately become available to put it to the test.
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